Hansen Carl L. G.

Hansen Carl L. G. is listed in filings as Chief Executive Officer at AbCellera Biologics Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 4 public disclosures. Recent filings connect the profile to AbCellera Biologics Inc. (ABCL). The current snapshot covers public activity from Sep 24, 2024 to Jan 5, 2026. Reported amounts are shown as $151.5K to $7.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.